Target intelligence / Profile preview

Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogeneA (UBA52 pseudogeneA)

Target
UBA52 pseudogeneA
Molecular classification
Pseudogene
01

Overview

Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogeneA (UBA52 pseudogeneA; ENSG00000239622) is a human pseudogene related to the functional UBA52 gene. Pseudogenes resemble known genes but are generally non-functional due to mutations or lack of regulatory elements; they do not encode proteins. Although pseudogenes were once considered "junk DNA," some are transcribed, and their RNA products can participate in regulatory networks by acting as decoys for microRNAs or generating non-coding RNAs that influence gene expression. However, this specific pseudogene is not considered a drug target or biomarker and does not encode an active protein.

02

Biological functions

May participate in regulation of gene expression at the RNA level, for instance, by acting as a decoy for microRNAs or producing non-coding RNAs that regulate parental gene functionContext-dependent regulatory roles (no standard biological function)
03

Disease associations

No specific disease roles identified for this pseudogene (general pseudogene functions may include involvement in cancer or other diseases due to regulatory effects)

Beyond the preview

Go deeper on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogeneA (UBA52 pseudogeneA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin A-52 residue ribosomal protein fusion product 1 pseudogeneA (UBA52 pseudogeneA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call